期刊文献+

二甲基亚砜诱导HL-60细胞分化的比较蛋白质组学研究

原文传递
导出
摘要 不同的诱导分化剂可诱导急性髓系白血病细胞系HL-60细胞向不同谱系的细胞分化。二甲基亚砜(DMSO)由于其溶解极性和非极性化合物能力极强而被广泛用作溶剂。
出处 《中华血液学杂志》 CAS CSCD 北大核心 2012年第3期238-240,共3页 Chinese Journal of Hematology
  • 相关文献

参考文献10

  • 1Abedin M.I, Kashio Y, Seki M, el al. Potential roles of gdectins in myelJid differ'entiation into three different liteages. J Leukoc Bi- o1,2003 ,73 :650-656.
  • 2Woods E J, Perth" BC, Hnekema JJ, et al. Optimized eryopreserva- tion method for human dental pulp-derived stem ceils and their tis- sues of origin for banding and clinical use. ClTnbinlogy, 2009,59: 150-157.
  • 3Stephens AS, Stephens SR, Hobbs C, el al. Myocyte etlhancer fiietor 2e: an osteoblast transeriptian factor identified by dimethyl sulfox- ide(DMSO) -enhanced mineralization. J Biol Chem, 2011, 286 : 30071-30086.
  • 4钱俊杰,应万涛,孙国敬,宋宜,刘斌,董燕,钱小红,孙志贤.亚细胞蛋白质组学技术分析MG132诱导HL-60细胞G_2/M期阻滞的分子机制[J].癌症,2006,25(5):533-537. 被引量:5
  • 5Srinivas PR, Kramer BS, Srivastava S. Trends in biomarker research for cancer detection. Lancet Oncol,2001,2 :698-704.
  • 6Bizzarro V, Fontanella B, Franceschelli S,et al. Role of Annexin AI in mouse myoblast cell differentiation. J Cell Physiol, 2010, 224 : 757-765.
  • 7Briinagel G,Stmh U, Sehoen RE,et al. Identification of calretieulin as a nuclear matrix protein a~dated with human colon camer. J Cell Bioehem, 2003, 89:238-243.
  • 8Lichtenfels R,Kellner R,Alkins D,et al. Identification of nltqaboL- ic enzymes in renal cell carcino utilizing PROTEOMEX analyses. Biochim Biophys Acla ,2003,1646 : 2 1 -3 1.
  • 9Chen G,Gharib TG, Huang CC, et al. Proteomic analysis of lung adenocarcinoma:identification of a highly expressed sel of proteins in Imuot's. Clin Cancer Res, 2002,8:2298-2305.
  • 10Hermann-Kleiler N, Chaftari-Tabrizi N, Blumer M J, et al. l,aspl misexpression itflluences chondmcyle differentialion in the verte- bral column. Int J Dev Biol, 2009, 53:983-991.

二级参考文献16

  • 1孙国敬,钱俊杰,孟祥兵,宋宜,张枫,梅柱中,董燕,孙志贤.蛋白酶体抑制剂MG132诱导HL-60细胞凋亡前G_2/M期阻滞及机制[J].癌症,2004,23(10):1144-1148. 被引量:12
  • 2Kastan M B, Bartek J. Cell-cycle checkpoints and cancer [J].Nature, 2004,432(7015) :316-323.
  • 3Ohta T, Fukuda M. Ubiquitin and breast cancer [J].Oncogene, 2004,23 ( 11 ) : 2079-2088.
  • 4Adams J. Preclinical and clinical evaluation of proteasome inhibitor PS-341 for the treatment of cancer [J]. Curr Opin Chem Biol, 2002,6(4) :493-500.
  • 5Wilkins M R, Sanchez J C, Cooley A A, et al. Progress with proteome projects: why all proteins expressed by a genome should be identified and how to do it [J]. Biotechnol Genet Eng Rev, 1996,13:19-50.
  • 6Blackstock W P, Weir M P. Proteomics: quantitative and physical mapping of cellular proteins [ J ]. Trends Biotechnol,1999,17(3) : 121-127.
  • 7斯佩克特,戈德曼,莱因万德,黄培堂,等译.细胞实验指南(上册)[M].北京:科学出版社,2004:374—375.
  • 8Rabilloud T, Adessi C, Giraudel A, et al. Improvement of the solubilization of proteins in two-dimensional electrophoresis with immobilized pH gradients [J]. Electrophoresis, 1997,18(3-4) :307-316.
  • 9Blomberg A, Blomberg L, Norbeck J, et al. Interlaboratory reproducibility of yeast protein patterns analyzed by immobilized pH gradient two-dimensional gel electrophoresis[J]. Electrophoresis, 1995,16(10) : 1935-1945.
  • 10Caraglia M, Tagliaferri P, Budillon A, et al. Posttranslational modifications of eukaryotic initiation factor-5A(elF-SA) as a new target for anti-cancer therapy [J]. AdvExp Med Biol, 1999,472( ) : 187-198.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部